Vaxcyte, Inc. PCVX Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s other operating expenses?
- Vaxcyte, Inc. (PCVX) reported other operating expenses of $345.85M in Q1 2026.
- How has Vaxcyte, Inc.'s other operating expenses changed year-over-year?
- Vaxcyte, Inc.'s other operating expenses increased by 91.3% year-over-year, from $180.79M to $345.85M.
- What is the long-term trend for Vaxcyte, Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s other operating expenses has grown at a 72.8% compound annual growth rate (CAGR), from $103.67M to $923.68M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.